Atormac
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 3815  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
  »  Article in PDF (526 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  

 
  In this Article
 »  Abstract
 » Introduction
 »  Natural History ...
 »  Identifying the ...
 »  Patient Characte...
 »  Morphological Ch...
 »  Hemodynamic Para...
 »  Decision Making ...
 »  Observation Vers...
 »  Surgical Clippin...
 »  Management of An...
 »  Prognosis and Lo...
 » Conclusion
 »  References
 »  Article Tables

 Article Access Statistics
    Viewed2607    
    Printed48    
    Emailed0    
    PDF Downloaded150    
    Comments [Add]    
    Cited by others 1    

Recommend this journal

 


 
Table of Contents    
REVIEW ARTICLE
Year : 2015  |  Volume : 63  |  Issue : 6  |  Page : 852-859

Treatment of unruptured intracranial aneurysms-Current perspective


1 Department of Neurological Surgery, Miller School of Medicine, University of Miami, Miami, Florida, USA
2 Department of Neurological Surgery, Manipal Hospital, Bangalore, Karnataka, India

Date of Web Publication20-Nov-2015

Correspondence Address:
Paritosh Pandey
Department of Neurological Surgery, Manipal Hospital, 98, HAL Airport Road, Bangalore - 560 017, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.170101

Rights and Permissions

 » Abstract 

Unruptured intracranial aneurysms (UIAs) present a unique challenge due to the lack of a clear understanding of their natural history and outcome. As the treatment of UIAs is aimed at preventing the possibility of rupture, the immediate risk of treatment must be weighed against the risk of rupture in the future. As such, no specific guidelines exist for a large proportion of UIAs, and treatment is currently individualized. It is also of paramount importance that the physicians be aware of the recent advances in the therapy of UIAs. The present article focuses on the recent advances in the understanding of UIAs.


Keywords: Aneurysm; intracranial; natural history; pharmacology; subarachnoid hemorrhage; unruptured


How to cite this article:
Ambekar S, Pandey P. Treatment of unruptured intracranial aneurysms-Current perspective. Neurol India 2015;63:852-9

How to cite this URL:
Ambekar S, Pandey P. Treatment of unruptured intracranial aneurysms-Current perspective. Neurol India [serial online] 2015 [cited 2020 Mar 29];63:852-9. Available from: http://www.neurologyindia.com/text.asp?2015/63/6/852/170101



 » Introduction Top


The management of unruptured intracranial aneurysms (UIAs) remains one of the most controversial topics in cerebrovascular surgery. As a result, there have been a number of studies that have attempted to evaluate the natural history of UIAs. Recently, the focus has shifted to characterizing the risk of rupture based on morphological and hemodynamic characteristics of aneurysms. With the increasing safety features and expanding indications of neurosurgical and neurointerventional techniques, it is all the more relevant in today's world to be able to clearly define the rupture risk of an unruptured aneurysm, and also streamline the indications of treatment.

Despite the advances in research, there is no clear consensus. While a small subset of aneurysms clearly falls in the category for observation or treatment, a large proportion of aneurysms are managed based on the treating physician's and patient's preferences and bias. Much of the earlier research depended on understanding the natural history and risk of rupture based on the patient characteristics and the basic aneurysmal morphology.

In this article, we discuss the recent developments in the understanding of unruptured intracranial aneurysms and their management.


 » Natural History of Unruptured Intracranial Aneurysms Top


The prevalence of UIAs has been variously cited between 1% and 6% in the general population.[1],[2],[3],[4],[5],[6],[7] In a large systematic review of more than 56,000 patients, the authors found that the prevalence of UIAs in adults without specific risk factors was 2.3% and tended to increase with age. The prevalence was higher in patients with autosomal-dominant polycystic kidney disease (relative risk [RR], 4.4), familial predisposition (RR, 4.0), and atherosclerosis (RR, 2.3)[8]

The International Study of Unruptured Intracranial Aneurysms (ISUIA) was a multicenter study of the natural history of UIAs. The study had two arms. In the retrospective arm, patients were divided into two groups, the first group consisting of patients without any history of subarachnoid hemorrhage (SAH; n = 727); and, the second group of patients with a history of SAH (n = 722). The mean follow-up duration was 8.3 years. For Group 1, the rate of SAH for aneurysms <10 mm in size was 0.05% per year, whereas for aneurysms ≥10 mm in size, it was approximately 1% per year. For Group 2, the SAH rate was 0.5% per year for aneurysms <10 mm in size and 1% per year for aneurysms ≥10 mm in size. Aneurysms in the posterior circulation and posterior communicating artery had a higher risk of rupture in Group 1, whereas increasing age and basilar bifurcation location were risk factors for a higher risk of rupture in Group 2.[9]

In the prospective arm, the patients were divided into the same two groups. Group I consisted of 1077 patients without a previous SAH, and Group II had 615 patients with a history of SAH. All aneurysms were confirmed with angiography and followed for 14.1 years. The rates of rupture in the internal carotid artery (ICA), middle cerebral artery, anterior cerebral artery, and anterior communicating artery (anterior circulation) for aneurysms <7 mm, 7–12 mm, 13–24 mm, and ≥25 mm in size were noted to be 0%, 2.6%, 14.5%, and 40%, respectively. In contrast, the rates of rupture for aneurysms located in the posterior communicating artery and posterior circulation were noted to be 2.5%, 14.5%, 18.4%, and 50%, respectively.[10]

One of the largest prospective studies on the natural history of UIAs comes from the Japanese cohort of 5720 subjects with 6697 aneurysms. The majority of aneurysms were either in the middle cerebral artery (36%) or the internal carotid artery (34%). The mean size of aneurysms was 5.7 ± 3.6 mm. During the follow-up period of 11,660 aneurysm-years, the authors reported an annual rupture rate of 0.95% (95% confidence interval [95% CI], 0.79–1.15). Aneurysms that were 5–6 mm in maximum diameter were not at higher risk of rupture than those with a maximum diameter of 3–4 mm, but the risk was increased for aneurysms that were ≥ 7 mm in diameter. The hazard ratios for size categories, compared with the aneurysms with a diameter of 3–4 mm, were as follows: 5–6 mm, 1.13 (95% CI, 0.58–2.22); 7–9 mm, 3.35 (1.87–6.00); 10–24 mm, 9.09 (5.25–15.74); and ≥ 25 mm, 76.26 (32.76–177.54). They also observed that aneurysms in the anterior and posterior communicating arteries were more likely to rupture when compared with those located in the middle cerebral artery.[11]

A recent retrospective study followed 140 patients for 21 years and reported a rate of rupture of approximately 1.1% per year. Aneurysm diameter >7 mm (P = 0.028), current cigarette smoking (P = 0.024), and heavy alcohol consumption (P = 0.043) were significantly associated with a higher aneurysmal rupture rate.[12]

[Table 1] lists the important studies describing the natural history of UIAs.
Table  1: Important studies of natural history of unruptured brain aneurysms

Click here to view



 » Identifying the Risk of Rupture of Unruptured Intracranial Aneurysms Top


One of the most intriguing aspects of intracranial aneurysms is determining the rupture risk in patients diagnosed with unruptured aneurysms. While the rupture risk in a particular subset of patients may be very small and subjecting these patients to any treatment (surgical or endovascular) may put them at a higher risk of complications than would be with natural history, another subset of patients may be at a higher risk of aneurysmal rupture and intervention rather than watchful waiting may be warranted. Again, the rupture risk is known to differ depending on a number of clinical, morphological, hemodynamic, and genetic characteristics. In this section, we discuss the putative factors that have a role in influencing rupture risk of cerebral aneurysms and should be taken into consideration while individualizing therapy.


 » Patient Characteristics Top


Race, age, gender, hypertension, smoking, history of subarachnoid hemorrhage (SAH), and number of aneurysms have all been proposed to influence the risk of rupture. It is well known that Finnish people have 3–6 times and the Japanese have 2–6 times increased risk of aneurysm rupture than people of North America and of European countries other than Finland.[16] This difference spans across aneurysms of all sizes. For example, in the International Study of Unruptured Intracranial Aneurysms (ISUIA), which involved predominantly Caucasian patients, the 5-year cumulative rupture risk in patients with anterior circulation aneurysms less than 7 mm in size and without a history of SAH was 0%,[10] whereas the annual rate of rupture in the Unruptured Cerebral Aneurysm Study (UCAS), which was performed in a Japanese cohort, was between 0.23% and 1% for anterior circulation aneurysms.[11] In the Small Unruptured Intracranial Aneurysm Verification Study (SUAVe), the annual rupture risk of single unruptured aneurysms <5 mm in diameter was 0.34% per year and that of multiple unruptured aneurysms was 0.95% per year, with an overall rate of 0.54% per year.[13]

An increasing age increases the rupture risk in an unruptured aneurysm. In a cumulative analysis of 8382 patients with 10,272 unruptured aneurysms from six cohort studies from North America and Europe, only 12% of patients with ruptured, and 5% with unruptured aneurysms, were less than 40 years of age. The 5-year predicted absolute risk of rupture ranged from 0.25% in individuals younger than 70 years without vascular risk factors and with an internal carotid artery aneurysm <7 mm in size to approximately 15% in patients aged 70 years or more with hypertension, a history of SAH, and a >20-mm posterior circulation aneurysm.[16] In a meta-analysis, patients older than 60 years had a two time higher risk of rupture than those younger than 60 years.[14]

More than two-thirds of all intracranial aneurysms occur in women. Among women, more than half of the aneurysms are located in the ICA (54%), while the anterior cerebral artery (ACA) is the most common location in men (29%). Women also tend to present later in life, with multiple aneurysms and with SAH.[17] The reason for most women presenting with ruptured aneurysms later in life may be linked to the protective effect of estrogen through the activation of estrogen receptor-β.[18]

Hypertension and cigarette smoking have long been recognized as risk factors for aneurysmal rupture. Presence of hypertension alone increases the risk of rupture three-fold even in small aneurysms less than 7 mm in diameter.[19] It has been demonstrated that cigarette smoking increases wall shear stress at the site of aneurysm initiation. It also promotes aneurysm growth and increases the rupture risk simultaneously by acting as a catalyst in a complex interplay of hemodynamic stress, vascular inflammation, and cerebral aneurysm formation.[20]

A history of SAH and the presence of multiple aneurysms have been shown to increase the risk of subsequent SAH in two Japanese studies. However, this effect has not been uniform across other studies, and their impact is uncertain.[13],[15]


 » Morphological Characteristics Top


A number of morphological indices have been proposed to correlate with and predict the rupture risk. The simplest parameter is aneurysm size. The ISUIA demonstrated that aneurysms less than 10 mm in size have a very low risk of rupture, and the 5-year cumulative rupture rate was 0%–2.5% for aneurysms <7 mm in size, 2.6%–14.5% for aneurysms 7–12 mm in size, 14.5%–18.4% for aneurysms 12–24 mm in size, and 40%–50% for aneurysms ≥25 mm size.[9],[10] Although ISUIA provided the first large, international, prospective data for decision making in the treatment of intracranial aneurysms, it had many limitations. Patients receiving treatment within 30 days of diagnosis were excluded in the retrospective cohort, leading to a selection bias. In addition, cavernous carotid aneurysms were over-represented, and patients who died of intracranial hemorrhage of unknown origin were not accounted for. However, the Finnish and Japanese studies revealed a 1.3%–2.3% risk of rupture even in patients with aneurysms <7 mm in size.[12],[21],[22] Location of the aneurysm also influences the predisposition to aneurysmal rupture. Posterior circulation aneurysms have been reported to rupture more often than anterior circulation aneurysms, and among the aneurysms located in the anterior circulation, those located at the anterior communicating artery and the origin of posterior communicating artery have a higher risk of rupture than elsewhere. Aneurysms with daughter sacs and wall irregularity have also been reported to have a higher rupture risk.[11],[23],[24],[25],[26]

Aspect ratio (AR) is defined as the ratio of the maximum perpendicular height to the average neck diameter, where the average neck diameter is calculated as twice the average distance from the neck centroid to the edge of the neck.[27] Ruptured aneurysms have been reported to have a higher AR than unruptured aneurysms. Ujiie et al., noted that a significantly higher proportion of unruptured aneurysms had an AR <1.6.[28] Weir et al., reported that the mean AR of unruptured and ruptured aneurysms was 1.8 and 3.4, respectively.[29] Other authors have variously reported the mean AR in ruptured aneurysms to be 2.24 and 2.7.[26],[30]

Size ratio (SR) refers to the ratio of the maximum aneurysm height to the average parent vessel diameter. The average parent vessel diameter is obtained by calculating the average of two vessel cross-sections upstream of the aneurysm. The maximum height is the maximum distance from the centroid of the aneurysm neck to any point on the aneurysm dome.[27] An SR of >2 has been associated with large areas of low wall shear stress (WSS) in the aneurysm that in turn predisposes to aneurysm growth and rupture.[31]

Other parameters such as ellipticity index; nonsphericity index; undulation index; vessel angle; aneurysm (inclination) angle; relationship between the aneurysm neck, parent artery, and daughter branches; daughter artery ratio, and lateral angle ratio have been proposed to predict the risk of rupture in unruptured aneurysms.[26],[27],[32]


 » Hemodynamic Parameters Top


Blood flow hemodynamics play a pivotal role in the initiation, growth, and rupture of intracranial aneurysms. Hassan et al., demonstrated that a high WSS may be responsible for growth and rupture of high-flow intracranial aneurysms, whereas high intra-aneurysmal pressure and flow stasis are responsible for rupture in low-flow aneurysms.[33] WSS is a dynamic frictional force induced by blood moving along the vessel wall. Low WSS can affect vascular remodeling and induce apoptosis of endothelial cells, resulting in vessel wall degeneration and aneurysmal growth and rupture.[33],[34],[35],[36] In contrast, high WSS has been proposed to induce degradation of the internal elastic lamina, resulting in aneurysm formation.[37] In another study, WSS and oscillatory shear index (OSI) were the only independent hemodynamic parameters that were significantly different in ruptured and unruptured aneurysms. OSI measures the directional change of WSS during a cardiac cycle.[38] Other proposed hemodynamic parameters that might have a role in aneurysmal growth and rupture include maximal intra-aneurysmal WSS (MWSS), low WSS area, WSS gradient (WSSG), number of vortices (NV), and relative resistance time (RRT).[38]

[Table 2] lists the factors affecting rupture of intracranial aneurysms
Table  2: Variables affecting risk of rupture of unruptured brain aneurysms

Click here to view



 » Decision Making in the Treatment of Uias Top


Management of UIAs is challenging. The various issues in decision making in the management of unruptured brain aneurysms (UBAs) include (1) observation versus treatment, (2) surgical clipping versus endovascular therapy (EVT), and (3) management of aneurysmal remnants.


 » Observation Versus Clipping/endovascular Therapy Top


With the increasing use of high-resolution neuroimaging techniques, more people with UIAs will be diagnosed each year, and a clear understanding of the current literature is paramount to optimize treatment. Treatment of UIAs is indicated when the risk of rupture from natural history is higher than the risk of treatment and follow-up. Not only does this imply that despite guidelines, therapy should be individualized, but also that the expertise of the individual center should be taken into consideration. The risk of treatment at a center varies depending on the expertise of the neurosurgeon, the neurointerventionist, and the support staff. Also, while there is a fair consensus across all populations regarding the treatment of aneurysms with known high-rupture-risk features such as female sex, young age, maximum size of ≥7 mm, anterior communicating artery, posterior communicating artery, or basilar bifurcation location, a history of subarachnoid hemorrhage, Finnish and Japanese descent, smoking, and hypertension, management of small aneurysms remain a matter of debate.

While natural history studies provide some information on the rupture risk of UIAs, they have certain limitations such as selection bias and not being applicable to the entire population across the world. The PHASES score was developed to estimate the risk of aneurysm rupture based on a pooled analysis of six studies.[16] It uses Population (North American or European, Japanese or Finnish descent), Hypertension, Age (<70 or ≥ 70 years), Size (<7 mm, 7–9.9 mm, 10–19.9 mm, and ≥20 mm), Earlier SAH, and Site of aneurysm to predict the risk of rupture. The 5-year absolute aneurysm rupture risk ranges from 0.25% in North American or European population other than those from Finland and in individuals younger than 70 years without vascular risk factors and with a small-sized (<7 mm) internal carotid artery aneurysm to >15% in patients aged ≥70 years with hypertension, a history of SAH, and a large (>20 mm) posterior circulation aneurysm. However, sex, smoking status, and presence of multiple aneurysms were not found to have a significant effect on the risk of rupture. More recently, the PHASES score has been correlated with aneurysm growth as well.[39]


 » Surgical Clipping Versus Endovascular Therapy Top


Very few areas in cerebrovascular medicine have created as much differences in opinion as the treatment of UBAs. With the rapid refinement of endovascular techniques and the introduction of flow diversion devices, EVT has become the first-line treatment of most UIAs. There has been no randomized trial of surgical clipping versus EVT for UIAs; however, numerous meta-analyses and systematic reviews have demonstrated the efficacy of EVT over clipping. In a systematic review, clipping resulted in significantly higher disability using the Modified Rankin Scale (odds ratio [OR], 2.83; 95% CI, 1.42–5.63) when compared with coiling. ORs for complications were also higher with clipping (ORs for neurological and cardiac complications were 1.94 and 2.51, respectively). Clipping resulted in significantly greater disability in the short term (≤6 months), but not in the long term (>6 months).[40]

The TEAM trial (Trial on Endovascular Aneurysm Management) was an international, randomized, multicenter, controlled trial comparing endovascular treatment and conservative management of UIAs. However, the study was suspended due to logistic reasons. The Canadian Unruptured Endovascular versus Surgery Trial (CURES) is a two-phase trial: the pilot Canadian phase intends to examine the incidence of treatment failure by 1 year, using a composite primary end point that includes anatomic outcomes,[41] and the second international phase aims to compare the clinical efficacy and safety of a surgical or endovascular management strategy at 1 and 5 years. The primary outcome measure is treatment failure, and the secondary outcome measures are morbidity and mortality, hospitalization >5 days, and discharge other than to home. The study is currently recruiting participants (https://www.clinicaltrials.gov/ct2/show/NCT01139892?term = NCT01139892 and rank = 1). [Table 3] lists the studies describing the outcome of surgical and EVT.
Table  3: Comparison of outcome following surgical clipping and endovascular therapy for unruptured intracranial aneurysms

Click here to view



 » Management of Aneurysm Remnants or Recanalization Top


Management of aneurysm remnant and recanalization after surgical clipping or EVT are other issues for debate. Re-treatment is a major event in that, in addition to being costly, places the patient at some risk, although much lower than that incurred during the primary treatment. In the long-term follow-up of patients in the International Subarachnoid Aneurysm Trial (ISAT), patients in the endovascular group were more likely to be alive and independent at 10 years than those in the neurosurgery group. The cumulative risk of a rebleed from the target aneurysm was 0.0216 for patients in the endovascular group and 0.0064 for patients in the neurosurgery group. Although the rebleed risk was small, the probability of disability-free survival was significantly greater in the endovascular group than in the neurosurgical group at 10 years.[54] It is not known whether the recurrent hemorrhages occurred only in patients with residual aneurysm filling or recanalized aneurysms. There is no such data available after treatment of UIAs. The term 'target aneurysm recurrence (TAR)' refers to the occurrence of more than one of the following events: (1) target aneurysm rupture, (2) sudden unexplained death, and (3) target aneurysm re-treatment. It is not yet known which aneurysm recurrences or residuals need to be treated to prevent delayed rehemorrhage. Until then, the decision to treat aneurysm recurrence or recanalization depends on individual patient and surgeon preference.


 » Prognosis and Long-Term Outcome of Uias Top


The initial prospective data on 798 patients, who underwent clipping in the ISUIA study, showed a mortality of 2.3% at 1 month and 3% at 1 year, which was slightly higher than that mentioned in previous studies. The combined morbidity (which included substantial functional disability or cognitive impairment) was approximately 13% in patients with a history of previous hemorrhage from another aneurysm as compared with 17.5% in those with no history of an aneurysm. The morbidity noted in ISUIA was higher than that seen in previous studies, primarily owing to the addition of cognitive impairment as a measure of morbidity, as this aspect was largely ignored in previous studies.[9] In a larger prospective cohort from ISUIA consisting of 1917 subjects, the morbidity and mortality rates at 1 year in patients who underwent open surgical repair were 12·6% for subjects with no history of SAH as compared with 10·1% for those with a history of SAH from other aneurysms. In both of these studies, a large size, location in posterior circulation, and advanced age were noted to be predictors of bad outcome.[9],[10] King et al., performed a meta-analysis of mortality and morbidity of elective surgery for asymptomatic aneurysms, which included 28 studies with more than 700 patients, and demonstrated a morbidity rate of 4.1% (95% CI, 2.8–5.8) and a mortality rate of 1.0% (95% CI, 0.4–2.0).[55] In a larger meta-analysis consisting of more than 2400 patients undergoing surgical treatment, a mortality rate of 2.6% and a morbidity rate of 10.9% were reported. The authors also reported that aneurysm location in the anterior circulation and its small size are associated with lower mortality and morbidity as compared with aneurysms in the posterior location and having a large size.[56]

Currently, with advancements in angiographic techniques, endovascular approach is rapidly becoming the standard of treatment, unless indicated otherwise. Johnston et al., observed that in-hospital death or discharge to a nursing home or rehabilitation hospital occurred in 10% of the patients treated with EVT compared with 25% of those treated surgically.[57] Prospective data from 498 patients treated with EVT in the ISUIA showed mortality and morbidity rates of 9.1% and 9.5% at 30 days and 1 year, respectively. An advanced age was not a predictor of bad outcome in subgroup analysis, suggesting that EVT might be more suitable for older patients.[10]


 » Conclusion Top


Recent data show that a number of morphological and hemodynamic changes and the perianeurysmal environment affect the rupture risk of intracranial aneurysms directly or indirectly. Given the uncertainty in the determination of rupture risk of a large proportion of unruptured intracranial aneurysms, we recommend that therapy should be individualized based on the outcomes at the treating center and patient preference.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
 » References Top

1.
Inagawa T, Ishikawa S, Aoki H, Takahashi M, Yoshimoto H. Aneurysmal subarachnoid hemorrhage in Izumo City and Shimane Prefecture of Japan. Incidence. Stroke 1988;19:170-5.  Back to cited text no. 1
    
2.
Stehbens WE. Aneurysms and anatomical variation of cerebral arteries. Arch Pathol 1963;75:45-64.  Back to cited text no. 2
[PUBMED]    
3.
Chason JL, Hindman WM. Berry aneurysms of the circle of Willis; results of a planned autopsy study. Neurology 1958;8:41-4.  Back to cited text no. 3
    
4.
Cohen MM. Cerebrovascular accidents; a study of two hundred one cases. AMA Arch Pathol 1955;60:296-307.  Back to cited text no. 4
[PUBMED]    
5.
Crompton MR. Mechanism of growth and rupture in cerebral berry aneurysms. Br Med J 1966;1:1138-42.  Back to cited text no. 5
[PUBMED]    
6.
de la Monte SM, Moore GW, Monk MA, Hutchins GM. Risk factors for the development and rupture of intracranial berry aneurysms. Am J Med 1985;78:957-64.  Back to cited text no. 6
[PUBMED]    
7.
McCormick WF, Acosta-Rua GJ. The size of intracranial saccular aneurysms. An autopsy study. J Neurosurg 1970;33:422-7.  Back to cited text no. 7
[PUBMED]    
8.
Rinkel GJ, Djibuti M, Algra A, van Gijn J. Prevalence and risk of rupture of intracranial aneurysms: A systematic review. Stroke 1998;29:251-6.  Back to cited text no. 8
    
9.
Unruptured intracranial aneurysms–risk of rupture and risks of surgical intervention. International study of unruptured intracranial aneurysms investigators. N Engl J Med 1998;339:1725-33.  Back to cited text no. 9
    
10.
Wiebers DO, Whisnant JP, Huston J 3rd, Meissner I, Brown RD Jr, Piepgras DG, et al.; International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: Natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003;362:103-10.  Back to cited text no. 10
    
11.
Morita A, Kirino T, Hashi K, Aoki N, Fukuhara S, Hashimoto N, et al.; UCAS Japan Investigators. The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med 2012;366:2474-82.  Back to cited text no. 11
[PUBMED]    
12.
Juvela S, Poussa K, Lehto H, Porras M. Natural history of unruptured intracranial aneurysms: A long-term follow-up study. Stroke 2013;44:2414-21.  Back to cited text no. 12
    
13.
Sonobe M, Yamazaki T, Yonekura M, Kikuchi H. Small unruptured intracranial aneurysm verification study: SUAVe study, Japan. Stroke 2010;41:1969-77.  Back to cited text no. 13
    
14.
Wermer MJ, van der Schaaf IC, Algra A, Rinkel GJ. Risk of rupture of unruptured intracranial aneurysms in relation to patient and aneurysm characteristics: An updated meta-analysis. Stroke 2007;38:1404-10.  Back to cited text no. 14
    
15.
Ishibashi T, Murayama Y, Urashima M, Saguchi T, Ebara M, Arakawa H, et al. Unruptured intracranial aneurysms: Incidence of rupture and risk factors. Stroke 2009;40:313-6.  Back to cited text no. 15
[PUBMED]    
16.
Greving JP, Wermer MJ, Brown RD Jr, Morita A, Juvela S, Yonekura M, et al. Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: A pooled analysis of six prospective cohort studies. Lancet Neurol 2014;13:59-66.  Back to cited text no. 16
    
17.
Ghods AJ, Lopes D, Chen M. Gender differences in cerebral aneurysm location. Front Neurol 2012;3:78.  Back to cited text no. 17
    
18.
Tada Y, Wada K, Shimada K, Makino H, Liang EI, Murakami S, et al. Estrogen protects against intracranial aneurysm rupture in ovariectomized mice. Hypertension 2014;63:1339-44.  Back to cited text no. 18
    
19.
Etminan N, Beseoglu K, Steiger HJ, Hänggi D. The impact of hypertension and nicotine on the size of ruptured intracranial aneurysms. J Neurol Neurosurg Psychiatry 2011;82:4-7.  Back to cited text no. 19
    
20.
Chalouhi N, Ali MS, Starke RM, Jabbour PM, Tjoumakaris SI, Gonzalez LF, et al. Cigarette smoke and inflammation: Role in cerebral aneurysm formation and rupture. Mediators Inflamm 2012;2012:271582.  Back to cited text no. 20
    
21.
Suga M, Yamamoto Y, Sunami N, Abe T, Michiue H. Rupture of previously documented asymptomatic unruptured aneurysms–aneurysm size: Risk factor for aneurysm rupture. No Shinkei Geka 2002;30:609-15.  Back to cited text no. 21
    
22.
Yasui N, Suzuki A, Nishimura H, Suzuki K, Abe T. Long-term follow-up study of unruptured intracranial aneurysms. Neurosurgery 1997;40:1155-60.  Back to cited text no. 22
    
23.
Beck J, Rohde S, el Beltagy M, Zimmermann M, Berkefeld J, Seifert V, et al. Difference in configuration of ruptured and unruptured intracranial aneurysms determined by biplanar digital subtraction angiography. Acta Neurochir (Wien) 2003;145:861-5.  Back to cited text no. 23
    
24.
Hademenos GJ, Massoud TF, Turjman F, Sayre JW. Anatomical and morphological factors correlating with rupture of intracranial aneurysms in patients referred for endovascular treatment. Neuroradiology 1998;40:755-60.  Back to cited text no. 24
    
25.
Ma B, Harbaugh RE, Raghavan ML. Three-dimensional geometrical characterization of cerebral aneurysms. Ann Biomed Eng 2004;32:264-73.  Back to cited text no. 25
    
26.
Sadatomo T, Yuki K, Migita K, Taniguchi E, Kodama Y, Kurisu K. Morphological differences between ruptured and unruptured cases in middle cerebral artery aneurysms. Neurosurgery 2008;62:602-9.  Back to cited text no. 26
    
27.
Dhar S, Tremmel M, Mocco J, Kim M, Yamamoto J, Siddiqui AH, et al. Morphology parameters for intracranial aneurysm rupture risk assessment. Neurosurgery 2008;63:185-97.  Back to cited text no. 27
    
28.
Ujiie H, Tamano Y, Sasaki K, Hori T. Is the aspect ratio a reliable index for predicting the rupture of a saccular aneurysm? Neurosurgery 2001;48:495-503.  Back to cited text no. 28
    
29.
Weir B, Amidei C, Kongable G, Findlay JM, Kassell NF, Kelly J, et al. The aspect ratio (dome/neck) of ruptured and unruptured aneurysms. J Neurosurg 2003;99:447-51.  Back to cited text no. 29
    
30.
Nader-Sepahi A, Casimiro M, Sen J, Kitchen ND. Is aspect ratio a reliable predictor of intracranial aneurysm rupture? Neurosurgery 2004;54:1343-7.  Back to cited text no. 30
    
31.
Tremmel M, Dhar S, Levy EI, Mocco J, Meng H. Influence of intracranial aneurysm-to-parent vessel size ratio on hemodynamics and implication for rupture: Results from a virtual experimental study. Neurosurgery 2009;64:622-31.  Back to cited text no. 31
    
32.
Ambekar S, Madhugiri V, Bollam P, Nanda A. Morphological differences between ruptured and unruptured basilar bifurcation aneurysms. J Neurol Surg B Skull Base 2013;74:91-6.  Back to cited text no. 32
    
33.
Lüscher TF, Tanner FC. Endothelial regulation of vascular tone and growth. Am J Hypertens 1993;6:283S-293S.  Back to cited text no. 33
    
34.
Stamler JS. Redox signaling: Nitrosylation and related target interactions of nitric oxide. Cell 1994;78:931-6.  Back to cited text no. 34
    
35.
Kadirvel R, Ding YH, Dai D, Zakaria H, Robertson AM, Danielson MA, et al. The influence of hemodynamic forces on biomarkers in the walls of elastase-induced aneurysms in rabbits. Neuroradiology 2007;49:1041-53.  Back to cited text no. 35
    
36.
Kaiser D, Freyberg MA, Friedl P. Lack of hemodynamic forces triggers apoptosis in vascular endothelial cells. Biochem Biophys Res Commun 1997;231:586-90.  Back to cited text no. 36
    
37.
Wang F, Xu B, Sun Z, Wu C, Zhang X. Wall shear stress in intracranial aneurysms and adjacent arteries. Neural Regen Res 2013;8:1007-15.  Back to cited text no. 37
  Medknow Journal  
38.
Xiang J, Natarajan SK, Tremmel M, Ma D, Mocco J, Hopkins LN, et al. Hemodynamic-morphologic discriminants for intracranial aneurysm rupture. Stroke 2011;42:144-52.  Back to cited text no. 38
    
39.
Backes D, Vergouwen MD, Tiel Groenestege AT, Bor AS, Velthuis BK, Greving JP, et al. PHASES score for prediction of intracranial aneurysm growth. Stroke 2015;46:1221-6.  Back to cited text no. 39
    
40.
Hwang JS, Hyun MK, Lee HJ, Choi JE, Kim JH, Lee NR, et al. Endovascular coiling versus neurosurgical clipping in patients with unruptured intracranial aneurysm: A systematic review. BMC Neurol 2012;12:99.  Back to cited text no. 40
    
41.
Darsaut TE, Findlay JM, Raymond J; CURES Collaborative Group. The design of the Canadian UnRuptured Endovascular versus Surgery (CURES) trial. Can J Neurol Sci 2011;38:236-41.  Back to cited text no. 41
    
42.
Ogilvy CS, Carter BS. Stratification of outcome for surgically treated unruptured intracranial aneurysms. Neurosurgery 2003;52:82-8.  Back to cited text no. 42
    
43.
Britz GW, Salem L, Newell DW, Eskridge J, Flum DR. Impact of surgical clipping on survival in unruptured and ruptured cerebral aneurysms: A population-based study. Stroke 2004;35:1399-403.  Back to cited text no. 43
    
44.
Moroi J, Hadeishi H, Suzuki A, Yasui N. Morbidity and mortality from surgical treatment of unruptured cerebral aneurysms at Research Institute for Brain and Blood Vessels-Akita. Neurosurgery 2005;56:224-31.  Back to cited text no. 44
    
45.
Kotowski M, Naggara O, Darsaut TE, Nolet S, Gevry G, Kouznetsov E, et al. Safety and occlusion rates of surgical treatment of unruptured intracranial aneurysms: A systematic review and meta-analysis of the literature from 1990 to 2011. J Neurol Neurosurg Psychiatry 2013;84:42-8.  Back to cited text no. 45
    
46.
Higashida RT, Lahue BJ, Torbey MT, Hopkins LN, Leip E, Hanley DF. Treatment of unruptured intracranial aneurysms: A nationwide assessment of effectiveness. AJNR Am J Neuroradiol 2007;28:146-51.  Back to cited text no. 46
    
47.
Sharma M, Brown B, Madhugiri V, Cuellar-Saenz H, Sonig A, Ambekar S, et al. Unruptured intracranial aneurysms: Comparison of perioperative complications, discharge disposition, outcome, and effect of calcification, between clipping and coiling: A single institution experience. Neurol India 2013;61:270-6.  Back to cited text no. 47
[PUBMED]  Medknow Journal  
48.
Ruan C, Long H, Sun H, He M, Yang K, Zhang H, et al. Endovascular coiling vs. surgical clipping for unruptured intracranial aneurysm: A meta-analysis. Br J Neurosurg 2015:1-8. [Epub ahead of print].  Back to cited text no. 48
    
49.
Song J, Kim BS, Shin YS. Treatment outcomes of unruptured intracranial aneurysm; experience of 1231 consecutive aneurysms. Acta Neurochir (Wien) 2015;157:1303-11.  Back to cited text no. 49
    
50.
Pierot L, Spelle L, Vitry F; ATENA Investigators. Immediate clinical outcome of patients harboring unruptured intracranial aneurysms treated by endovascular approach: Results of the ATENA study. Stroke 2008;39:2497-504.  Back to cited text no. 50
[PUBMED]    
51.
Murayama Y, Nien YL, Duckwiler G, Gobin YP, Jahan R, Frazee J, et al. Guglielmi detachable coil embolization of cerebral aneurysms: 11 years' experience. J Neurosurg 2003;98:959-66.  Back to cited text no. 51
    
52.
Benes V 3rd, Mitchell P, Molyneux AJ, Renowden SA. Endovascular coiling in 131 patients with low complication rate justifies treating most unruptured intracranial aneurysms. Cent Eur Neurosurg 2010;71:1-7.  Back to cited text no. 52
    
53.
Naggara ON, Lecler A, Oppenheim C, Meder JF, Raymond J. Endovascular treatment of intracranial unruptured aneurysms: A systematic review of the literature on safety with emphasis on subgroup analyses. Radiology 2012;263:828-35.  Back to cited text no. 53
    
54.
Molyneux AJ, Birks J, Clarke A, Sneade M, Kerr RS. The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms: 18 year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT). Lancet 2015;385:691-7.  Back to cited text no. 54
    
55.
King JT Jr, Berlin JA, Flamm ES. Morbidity and mortality from elective surgery for asymptomatic, unruptured, intracranial aneurysms: A meta-analysis. J Neurosurg 1994;81:837-42.  Back to cited text no. 55
    
56.
Raaymakers TW, Rinkel GJ, Limburg M, Algra A. Mortality and morbidity of surgery for unruptured intracranial aneurysms: A meta-analysis. Stroke 1998;29:1531-8.  Back to cited text no. 56
    
57.
Johnston SC, Zhao S, Dudley RA, Berman MF, Gress DR. Treatment of unruptured cerebral aneurysms in California. Stroke 2001;32:597-605.  Back to cited text no. 57
    



 
 
    Tables

  [Table 1], [Table 2], [Table 3]

This article has been cited by
1 Microsurgical Repair of Ruptured Aneurysms Associated with Moyamoya-Pattern Collateral Vessels of the Middle Cerebral Artery: A Report of Two Cases
Min Lang,Nina Z. Moore,Alex M. Witek,Varun R. Kshettry,Mark D. Bain
World Neurosurgery. 2017; 105: 1042.e5
[Pubmed] | [DOI]



 

Top
Print this article  Email this article
   
Online since 20th March '04
Published by Wolters Kluwer - Medknow